March 3, 2026 · Form 4 insider transaction
O'Neill Gilmore Neil sold 5,394 shares of Editas Medicine, Inc. at $2.02 per share, a transaction worth $10.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.; This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204 The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.